Document is current
Any future updates will be listed below
-
Authors
Knighton, Andrew J. https://orcid.org/0000-0002-8276-0454
Kean, Jacob
Peltan, Ithan D. https://orcid.org/0000-0003-1730-234X
Lisonbee, Dee
Krueger, Ashley
Wolfe, Doug
Winberg, Carrie M.
Sillito, Corey
Jones, Christopher B.
Carpenter, Lori
Jacobs, Jason R. https://orcid.org/0000-0002-3406-0410
Leither, Lindsay
Holubkov, Richard
Grissom, Colin K. https://orcid.org/0000-0001-9477-272X
Srivastava, Raj
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (U01 HL159878)
- License Information
-
More Information
Article History
Received: 30 October 2024
Accepted: 23 July 2025
First Online: 25 August 2025
Declarations
:
: The Intermountain Health Institutional Review Board reviewed this study and granted approval with a waiver of documentation of informed consent (#1052246).
: Not applicable.
: AJK, JK, DL, AK, DW, CW, CS, CJ, LC, JRJ, LL and CG – the authors have no competing financial or non-financial interests.IP—Dr. Peltan reports funding to his institution from Bluejay Diagnostics and Novartis, both unaffiliated with this research.RH – Dr. Holubkov reports a consulting arrangement with Pfizer Inc (DSMB memberships) unaffiliated with this research.RS—Dr. Srivastava is a physician founder of the I-PASS Patient Safety Institute. His employer, Intermountain Health, owns his equity in the I-PASS Patient Safety Institute. Dr. Srivastava is supported in part by grants from the NIH, CDC, AHRQ and PCORI. Dr. Srivastava has received monetary awards, honorariums, and travel reimbursement from multiple academic and professional organizations for talks about pediatric hospitalist research networks and quality of care.
